| |
| |
|
| Insider
Information: |
Arbuckle Stuart A |
| Relationship: |
Director |
| City: |
Cambridge, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
62,795 |
|
|
Indirect Shares
|
140 |
|
|
| Direct
Value |
$22,712,016 |
|
|
|
Indirect Value
|
$63,973 |
|
|
| Total
Shares |
62,935 |
|
|
| Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$14,441,830 |
D/D |
(89,400) |
131,467 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-10-31 |
4 |
AS |
$142.18 |
$10,860,645 |
D/D |
(75,000) |
41,952 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-07-19 |
4 |
OE |
$91.05 |
$9,587,718 |
D/D |
89,400 |
220,867 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-04-27 |
4 |
AS |
$127.49 |
$7,952,758 |
D/D |
(61,480) |
127,515 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-06-02 |
4 |
AS |
$129.02 |
$7,402,523 |
D/D |
(57,375) |
131,467 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2022-08-15 |
4 |
AS |
$300.30 |
$6,738,991 |
D/D |
(22,173) |
45,278 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2019-02-11 |
4 |
AS |
$179.44 |
$5,959,969 |
D/D |
(33,073) |
38,864 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-09-19 |
4 |
AS |
$100.00 |
$5,552,100 |
D/D |
(55,521) |
54,681 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-06-02 |
4 |
OE |
$77.31 |
$4,628,505 |
D/D |
57,375 |
188,842 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-12-13 |
4 |
AS |
$399.00 |
$3,432,597 |
D/D |
(8,603) |
56,556 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2019-02-04 |
4 |
AS |
$184.81 |
$3,409,082 |
D/D |
(18,309) |
36,402 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-04-28 |
4 |
AS |
$119.50 |
$3,384,240 |
D/D |
(28,320) |
131,247 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-04-27 |
4 |
OE |
$45.11 |
$3,000,404 |
D/D |
50,875 |
188,995 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2015-08-05 |
4 |
AS |
$140.51 |
$2,801,202 |
D/D |
(19,828) |
127,515 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-02-11 |
4 |
AS |
$243.76 |
$2,777,325 |
D/D |
(11,286) |
47,335 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2014-09-19 |
4 |
OE |
$45.11 |
$2,601,285 |
D/D |
52,500 |
110,202 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
• – – |
2020-02-10 |
4 |
D |
$240.95 |
$2,154,575 |
D/D |
(8,942) |
58,621 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-26 |
4 |
AS |
$425.70 |
$2,142,974 |
D/D |
(5,034) |
49,691 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$2,035,458 |
D/D |
(4,714) |
54,725 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-20 |
4 |
AS |
$420.79 |
$2,021,475 |
D/D |
(4,804) |
63,042 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
• – – |
2017-07-21 |
4 |
AS |
$159.00 |
$2,011,271 |
D/D |
(12,475) |
121,117 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-14 |
4 |
AS |
$295.84 |
$1,910,962 |
D/D |
(6,398) |
75,605 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$1,907,621 |
D/D |
(4,499) |
71,219 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2024-02-12 |
4 |
AS |
$420.24 |
$1,804,931 |
D/D |
(4,295) |
75,718 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2023-02-13 |
4 |
D |
$298.26 |
$1,786,577 |
D/D |
(5,990) |
86,890 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
